CYP3A4 and thyroid gland carcinoma: The novel results showing the allosterically modulated CYP3A4-catalyzed oxidation of vandetanib, in addition to a new finding of a decrease in FMO-mediated generation of vandetanib-N-oxide by methimazol, are challenges for further investigation and potential utilization to improve treatment of thyroid cancer with vandetanib.